Skip to content
HomeOur CompanyOur societal impact Global Health Equity Pioneering the next generation of treatment solutions

Pioneering the next generation of treatment solutions

We support innovation across the continuum of care, to help to develop new technologies, treatments and vaccines.

The new Ebola clinical trial that’s focused on helping halt future outbreaks

A groundbreaking partnership between countries, health organizations and companies worldwide—including Johnson & Johnson—hopes to find the most promising vaccines to help protect people from the virus.

Featured stories

Meet the Johnson & Johnson Scientist Who’s Helping to Fight Tropical Diseases in His Homeland

Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.

Janssen Wins Prestigious International Prix Galien Award for MDR-TB Treatment

Ground breaking therapy offers hope for people with Multi-Drug Resistant Tuberculosis (MDR-TB)

How Johnson & Johnson is helping save children around the world from intestinal worm infections

For the fifth anniversary of the London Declaration, we’re sharing the steps the company has taken to fulfill its promise to fight neglected tropical diseases—including the development of a chewable form of mebendazole.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.